Safety profiles of hemophilia agents vary widely
Pediatric News ,
Despite their similar functions, each current and emerging therapy for treating hemophilia has a unique safety profile, and…
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1)
Overview of attention for article published in Journal of Thrombosis & Haemostasis, November 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 35 Mendeley